HomeTARS • NASDAQ
add
Tarsus Pharmaceuticals Inc
Previous close
$38.58
Day range
$36.73 - $38.60
Year range
$12.57 - $42.50
Market cap
1.44B USD
Avg Volume
593.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 27.61M | 1,004.56% |
Operating expense | 63.64M | 131.84% |
Net income | -35.73M | -52.57% |
Net profit margin | -129.39 | 86.19% |
Earnings per share | -0.99 | -13.40% |
EBITDA | -37.41M | -50.57% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 298.52M | 48.36% |
Total assets | 349.28M | 65.37% |
Total liabilities | 74.07M | 95.89% |
Total equity | 275.21M | — |
Shares outstanding | 37.78M | — |
Price to book | 5.29 | — |
Return on assets | -30.65% | — |
Return on capital | -35.15% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -35.73M | -52.57% |
Cash from operations | -37.79M | -72.00% |
Cash from investing | -102.22M | -1,005.12% |
Cash from financing | 108.77M | 2,069.78% |
Net change in cash | -31.24M | -451.69% |
Free cash flow | -26.54M | -96.54% |
About
Founded
2016
Headquarters
Website
Employees
244